What is the optimal peri‑operative management for a newly diagnosed primary polycythemia vera patient requiring emergency surgery?

Emergency Surgery in Newly Diagnosed Polycythemia Vera

Proceed with emergency surgery immediately when clinically necessary, with close postoperative surveillance for thrombosis and bleeding, as delaying life-saving procedures poses greater risk than the hematologic abnormalities. 1

Immediate Preoperative Management

Multidisciplinary coordination between surgical, anesthesia, and hematology teams is essential before proceeding. 1 Review the patient's bleeding and thrombosis history, though in newly diagnosed patients this may be limited. 1

Hematocrit Control

• Do not delay emergency surgery to achieve optimal hematocrit control, as this is only feasible for elective procedures. 1
• For elective surgery, hematocrit should be controlled to <45% for 3 months prior to the procedure, but this timeline is impossible in emergency settings. 1
• If time permits (even hours), consider emergent phlebotomy to reduce hematocrit, though this should not delay life-saving surgery. 2

Cytoreductive Therapy Considerations

• Hydroxyurea can be initiated perioperatively if the patient is newly diagnosed, as cytoreductive therapy can typically be continued throughout the perioperative period unless contraindicated by the surgical team. 1, 2
• The goal is to control white blood cell and platelet counts to reduce thrombotic risk. 2

Antiplatelet and Anticoagulation Strategy

Aspirin Management

• Withhold aspirin if there is active bleeding or high bleeding-risk surgery. 1
• If aspirin was being taken, it should be discontinued one week prior to elective surgery, but in emergency settings, proceed without it. 1
• Restart aspirin 24 hours after surgery when hemostasis is adequate and bleeding risk is acceptable. 1

Thromboprophylaxis

• Administer prophylactic LMWH postoperatively when adequate surgical hemostasis is achieved, typically 12-24 hours after surgery. 1
• For high-risk procedures (orthopedic, cardiovascular, cancer surgery, or procedures with prolonged immobilization), consider extended prophylaxis with LMWH. 1
• The timing of LMWH resumption should be delayed 48-72 hours for high-bleeding-risk surgeries. 3

Intraoperative Considerations

Coagulation Assessment

• Obtain coagulation studies to evaluate for acquired von Willebrand disease or other coagulopathies, particularly if platelet count is elevated or splenomegaly is present. 1
• These tests are especially important for high-risk surgical procedures. 1

Anesthesia Considerations

• Maintain adequate hydration to prevent increased blood viscosity. 4
• Avoid hypothermia, which can exacerbate thrombotic risk. 4
• Monitor for signs of compromised end-organ perfusion due to hyperviscosity. 4

Postoperative Surveillance

Close monitoring for both thrombotic and hemorrhagic complications is mandatory. 1

Thrombotic Complications

• PV patients face dual risk: arterial thrombosis (more common in essential thrombocythemia) and venous thrombosis (more common in PV, occurring in 7.7% of surgeries). 5
• Venous events are particularly elevated in PV compared to essential thrombocythemia (7.7% vs 1.1%). 5
• Monitor for symptoms of deep vein thrombosis, pulmonary embolism, and arterial occlusion. 1

Hemorrhagic Complications

• Major hemorrhage occurs in approximately 7.3% of surgeries in PV patients despite optimal management. 5
• PV patients have increased likelihood of requiring blood product transfusion intraoperatively (OR 4.35) and during hospitalization (OR 4.35). 6
• Bleeding risk does not correlate with use of antithrombotic prophylaxis or type of surgery, suggesting it is inherent to the disease. 5

Critical Pitfalls to Avoid

Do Not Delay Life-Saving Surgery

• Only life-saving procedures should be performed in the critical period after any recent coronary stent placement if the patient happens to have one, but emergency surgery for other indications should proceed as necessary. 7
• The thrombotic and bleeding risks of PV are substantial but do not outweigh the need for emergency intervention. 1

Avoid Inadequate Prophylaxis

• Failure to provide adequate postoperative thromboprophylaxis exposes patients to the 7.7% venous thrombosis risk documented in retrospective studies. 5
• However, prophylaxis must be balanced against the 7.3% major hemorrhage risk. 5

Monitor for Splanchnic Thrombosis

• In patients with splenomegaly or portal hypertension who develop gastrointestinal bleeding, consult gastroenterology or hepatology for endoscopic evaluation, as gastric varices may be present. 1

Long-term Postoperative Management

• Initiate or continue cytoreductive therapy postoperatively to maintain hematocrit <45% and normalize blood counts. 1
• Assess need for long-term anticoagulation based on any thrombotic events that occur, with duration dependent on severity (abdominal vein thrombosis requires longer treatment than peripheral deep vein thrombosis). 1
• Consider plateletpheresis only if acute life-threatening thrombosis occurs postoperatively. 1